Nu Skin Enterprises, Inc.
NUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $364 | $386 | $364 | $446 |
| % Growth | -5.7% | 5.9% | -18.2% | – |
| Cost of Goods Sold | $107 | $120 | $118 | $166 |
| Gross Profit | $257 | $266 | $247 | $279 |
| % Margin | 70.5% | 68.8% | 67.8% | 62.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $105 | $107 | $113 | $121 |
| SG&A Expenses | $235 | $235 | $232 | $286 |
| Sales & Mktg Exp. | $130 | $128 | $119 | $165 |
| Other Operating Expenses | $0 | $0 | $25 | $46 |
| Operating Expenses | $235 | $235 | $257 | $332 |
| Operating Income | $22 | $31 | -$10 | -$53 |
| % Margin | 5.9% | 8% | -2.7% | -11.9% |
| Other Income/Exp. Net | -$6 | -$3 | $145 | -$5 |
| Pre-Tax Income | $16 | $27 | $135 | -$58 |
| Tax Expense | -$1 | $6 | $27 | -$22 |
| Net Income | $17 | $21 | $108 | -$36 |
| % Margin | 4.7% | 5.5% | 29.5% | -8.1% |
| EPS | 0.35 | 0.43 | 2.16 | -0.73 |
| % Growth | -18.6% | -80.1% | 395.9% | – |
| EPS Diluted | 0.34 | 0.43 | 2.14 | -0.73 |
| Weighted Avg Shares Out | 49 | 49 | 50 | 50 |
| Weighted Avg Shares Out Dil | 50 | 49 | 50 | 50 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $3 | $3 | $6 |
| Depreciation & Amortization | $12 | $13 | $14 | $16 |
| EBITDA | $32 | $43 | $152 | -$35 |
| % Margin | 8.8% | 11.1% | 41.7% | -8% |